-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL INC : LEERINK PARTNERS CUTS TARGET PRICE TO $70 FROM $80

Reuters·12/30/2025 04:09:37

Please log in to view news